FindTrial
Sign In

ADR reporting knowledge in consumers in tertiary care hospital

Knowledge, Attitude, Perception of Suspected Adverse Drug Reactions in Consumers in a Tertiary Care Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/10/016083
Enrollment
200
Registered
2018-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z000- Encounter for general adult medical examination

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Leeyasid shaik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients attending OPDs wards and pharmacy

Exclusion criteria

Exclusion criteria: Not willing to give written informed consent

Design outcomes

Primary

MeasureTime frame
Majority of consumers dont have idea about Pharmacovigilance and ADR reportingTimepoint: Six months—

Secondary

MeasureTime frame
Knowledge about ADRâ??s is low in consumers, need advocacy and improvement Consumer ADR reporting will be additive to the current pharmacovigilance system Not only the reported ADRâ??s due to prescribed drugs by health care professionals, consumer reporting will cover for OTC drugs too. The awareness about ADR reporting systems for consumers through the establishment of Consumer PV center in hospitals , pharmacies , mail ID, and through toll free numbersTimepoint: At 1 year—

Countries

India

Contacts

Public ContactDr Vasundara k

Kempegowda institute of medical sciences and research center

vasundarakrishnaiah@yahoo.co.in9480333963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026